Amgen Inc.
CH ˙ SWX ˙ NL0000888691
SecurityCH:AMGN / Amgen Inc.
InstitutionMidwest Professional Planners, LTD.
Latest Disclosed Ownership6,677 shares
Latest Disclosed Value $ 2,349,183
Midwest Professional Planners, LTD. reports 0.04% decrease in ownership of AMGN / Amgen Inc.

On May 5, 2026 - Midwest Professional Planners, LTD. filed a 13F-HR form disclosing ownership of 6,677 shares of Amgen Inc. (CH:AMGN) valued at $2,349,183 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 6, 2026 disclosing 6,680 shares of Amgen Inc.. This represents a change in shares of -0.04% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-05 2026-03-31 13F AMGEN COM 031162100 6,677 -3 -0.04 2,349 7.46 0.5534
2026-02-06 2025-12-31 13F AMGEN COM 031162100 6,680 224 3.47 2,186 20.04 0.5179
2025-11-04 2025-09-30 13F AMGEN COM 031162100 6,456 -122 -1.85 1,822 -0.82 0.4445
2025-08-11 2025-06-30 13F AMGEN COM 031162100 6,578 1 0.02 1,837 -10.40 0.4836
2025-05-02 2025-03-31 13F AMGEN COM 031162100 6,577 -168 -2.49 2,049 16.55 0.6377
2025-02-10 2024-12-31 13F AMGEN COM 031162100 6,745 -1,652 -19.67 1,758 -35.01 0.5250
2024-11-14 2024-09-30 13F AMGEN COM 031162100 8,397 330 4.09 2,706 7.34 0.8272
2024-08-06 2024-06-30 13F AMGEN COM 031162100 8,067 -21 -0.26 2,521 9.61 0.8424
2024-05-09 2024-03-31 13F AMGEN COM 031162100 8,088 -151 -1.83 2,300 -3.12 0.8067
2024-02-15 2023-12-31 13F AMGEN COM 031162100 8,239 577 7.53 2,373 15.25 0.9460
2024-02-15 2023-12-31 13F AMGEN COM 031162100 8,239 577 2,373 0.9460
2023-11-13 2023-09-30 13F AMGEN COM 031162100 7,662 852 12.51 2,059 36.18 0.9260
2023-08-07 2023-06-30 13F AMGEN COM 031162100 6,810 849 14.24 1,512 4.93 0.6623
2023-05-15 2023-03-31 13F AMGEN COM 031162100 5,961 -71 -1.18 1,441 -9.03 0.7050
2023-02-10 2022-12-31 13F AMGEN COM 031162100 6,032 439 7.85 1,584 25.61 0.8768
2022-11-10 2022-09-30 13F AMGEN COM 031162100 5,593 415 8.01 1,261 0.08 0.7524
2022-08-09 2022-06-30 13F AMGEN COM 031162100 5,178 313 6.43 1,260 7.14 0.7107
2022-05-11 2022-03-31 13F AMGEN COM 031162100 4,865 319 7.02 1,176 14.96 0.5785
2022-02-10 2021-12-31 13F AMGEN COM 031162100 4,546 132 2.99 1,023 8.95 0.4970
2021-11-08 2021-09-30 13F AMGEN COM 031162100 4,414 50 1.15 939 -11.75 0.4980
2021-08-10 2021-06-30 13F AMGEN COM 031162100 4,364 612 16.31 1,064 39.82 0.5543
2021-05-17 2021-03-31 13F Amgen COM 031162100 3,752 -514 -12.05 761 -22.43 0.7515
2021-03-11 2020-12-31 13F AMGEN COM 031162100 4,266 105 2.52 981 -7.28 0.6044
2020-11-06 2020-09-30 13F Amgen COM 031162100 4,161 249 6.37 1,058 14.63 0.7442
2020-08-14 2020-06-30 13F Amgen COM 031162100 3,912 160 4.26 923 21.29 0.7268
2020-05-05 2020-03-31 13F Amgen COM 031162100 3,752 135 3.73 761 -12.73 0.7515
2020-02-11 2019-12-31 13F Amgen COM 031162100 3,617 109 3.11 872 28.42 0.7122
2019-11-14 2019-09-30 13F Amgen COM 031162100 3,508 1,252 55.50 679 63.22 0.6074
2019-08-12 2019-06-30 13F Amgen COM 031162100 2,256 11 0.49 416 -2.58 0.3859
2019-05-08 2019-03-31 13F Amgen COM 031162100 2,245 -1,989 -46.98 427 -48.18 0.4122
2019-02-13 2018-12-31 13F Amgen COM 031162100 4,234 -42 -0.98 824 -7.00 0.8870
2018-11-13 2018-09-30 13F Amgen COM 031162100 4,276 110 2.64 886 15.21 0.8135
2018-08-10 2018-06-30 13F Amgen COM 031162100 4,166 101 2.48 769 10.97 0.6876
2018-05-15 2018-03-31 13F Amgen COM 031162100 4,065 131 3.33 693 1.32 0.6245
2018-02-12 2017-12-31 13F AMGEN INC COM COM 031162100 3,934 3,934 684 0.6246
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.